Wednesday 29th July 2020, 1:00pm
Roslin Technologies is bolstering its offering for the veterinary and agricultural sectors with a range of four monoclonal antibodies, emanating from the UK-wide “Immunological Toolbox” project.
The antibodies, which have been developed by scientists at the Roslin Institute, will be commercialised by Roslin Technologies under an exclusive licence.
The antibodies will support research in poultry and pigs, to advance the understanding of immune responses to disease in these key livestock species.
The product range includes conjugated anti-porcine Adhesion G Protein-Coupled Receptor E1 (ADGRE-1), anti-chicken colony stimulating factor 1 (CSF1) and anti-porcine colony stimulating factor 1 (CSF1) use in ELISA, flow cytometry and immunohistochemistry studies.
The new offering was developed as part of the “Immunological Toolbox” initiative, a UK-wide project to develop and test immunological reagents that will underpin a variety of studies and ultimately promote animal health research and veterinary vaccine development.
“We are delighted to work with Roslin Technologies to offer these newly developed monoclonal antibodies which will facilitate detailed studies of pig and chicken innate immune responses. The aim of the Immunological Toolbox is to provide high quality reagents to the research community and our links with Roslin Technologies enable us to do this effectively.”
Professor Jayne Hope, lead of the Immunological Toolbox at the Roslin Institute“We are very pleased to be working with Professor Hope in bringing these immunological reagents to market. These tools are a further addition to our portfolio of animal health products to support livestock production.”
Professor Jacqui Matthews, CTO at Roslin TechnologiesSource: Roslin Technologies Ltd
Roslin Innovation Centre
The University of Edinburgh
Easter Bush Campus
Midlothian EH25 9RG
